What theyre saying: While the new generation of incretin therapies have been revolutionary for patients living with obesity, bimagrumab addresses a critical unmet need as a therapeutic that targets fat loss while building muscle mass. Versanis CEO Mark Pruzanski The solo act The drug: Altimmunes pemvidutide is a combination GLP-1 agonist and glucagon agonist
Orforglipron is oral, non-peptide, and doesnt require food timingmaking it a potential game-changer for patients who prefer pills over injections
Mt s tm kim cho thy Glutathione c bo ch di cc dng bao gm dng bt, cht lng, vin nang, ng ht, tim tnh mch (IV)
The New York Times .
It is not a drug, supplement, cosmetic, food, or medical device, and it is not for human or veterinary use of any kind
l carnitine 1000 1000 lsp 1000 .